$5.29
arrow_drop_down5.53%Key Stats | |
---|---|
Open | $5.61 |
Prev. Close | $5.60 |
EPS | -1.33 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 5.21 | 5.69 |
52 Week Range | 0.72 | 6.18 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.33 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update